Eosinophilic esophagitis and Rubinstein‐Taybi syndrome: A case series

Abstract Objectives Rubinstein‐Taybi syndrome (RTS) is a rare disorder characterized by intellectual disability, poor growth, distinctive facial features, and gastrointestinal (GI) symptoms. While dysphagia and feeding difficulties are well recognized in RTS, the prevalence and clinical significance of eosinophilic esophagitis (EoE) in this population remains unclear. Methods We conducted a retrospective case series at a single pediatric tertiary care center (2012–2022) collecting demographic, genetic, clinical, endoscopic, and histopathological data. Results Twenty‐seven patients with RTS were identified; 15 (56%) had an identifiable genetic variant (12 with CREBBP and 3 with EP300 ). Seventeen patients (63%) had GI symptoms and 8 (30%) underwent endoscopy. Four patients (15%) were diagnosed with EoE, with one patient also having eosinophilic gastritis and eosinophilic duodenitis. Age at diagnosis ranged from 8 months to 23 years. Presenting symptoms included food impaction, vomiting, dysphagia, and poor weight gain. Three of the 4 patients had RTS type 1 ( CREBBP variant gene). Treatments included proton pump inhibitors, swallowed steroids, and dietary elimination with variable responses. Compared with the general population, the odds of EoE in our RTS cohort were 121‐fold higher (odds ratio = 121.6, 95% confidence interval: 13.1–1131.0, p < 0.0001). Conclusion There is a markedly increased prevalence of EoE in patients with RTS. Early recognition and evaluation of GI symptoms with endoscopic assessment is important to enable timely diagnosis, optimize management, and reduce the risk of EoE‐related complications. Further research is needed to understand the underlying genetic and immunologic mechanisms linking RTS and EoE.

Authors

Institutions

Publication Details

Journal
JPGN Reports
Published
2026-11-17
DOI
https://doi.org/10.1002/jpr3.70305
Primary Topic
Eosinophilic Esophagitis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Eosinophilic esophagitis and Rubinstein‐Taybi syndrome: A case series

Christine R. F. Rukasin, Shauna R. Schroeder, Benjamin L. Wright, Ellen Ruan et al.
3 links
JPGN Reports
Eosinophilic Esophagitis
article

Eosinophilic esophagitis and Rubinstein‐Taybi syndrome: A case series

Christine R. F. Rukasin, Shauna R. Schroeder, Benjamin L. Wright, Ellen Ruan, Anita M. Husain, Jonathon G. Schening
article en

Abstract

Abstract Objectives Rubinstein‐Taybi syndrome (RTS) is a rare disorder characterized by intellectual disability, poor growth, distinctive facial features, and gastrointestinal (GI) symptoms. While dysphagia and feeding difficulties are well recognized in RTS, the prevalence and clinical significance of eosinophilic esophagitis (EoE) in this population remains unclear. Methods We conducted a retrospective case series at a single pediatric tertiary care center (2012–2022) collecting demographic, genetic, clinical, endoscopic, and histopathological data. Results Twenty‐seven patients with RTS were identified; 15 (56%) had an identifiable genetic variant (12 with CREBBP and 3 with EP300 ). Seventeen patients (63%) had GI symptoms and 8 (30%) underwent endoscopy. Four patients (15%) were diagnosed with EoE, with one patient also having eosinophilic gastritis and eosinophilic duodenitis. Age at diagnosis ranged from 8 months to 23 years. Presenting symptoms included food impaction, vomiting, dysphagia, and poor weight gain. Three of the 4 patients had RTS type 1 ( CREBBP variant gene). Treatments included proton pump inhibitors, swallowed steroids, and dietary elimination with variable responses. Compared with the general population, the odds of EoE in our RTS cohort were 121‐fold higher (odds ratio = 121.6, 95% confidence interval: 13.1–1131.0, p < 0.0001). Conclusion There is a markedly increased prevalence of EoE in patients with RTS. Early recognition and evaluation of GI symptoms with endoscopic assessment is important to enable timely diagnosis, optimize management, and reduce the risk of EoE‐related complications. Further research is needed to understand the underlying genetic and immunologic mechanisms linking RTS and EoE.

JPGN Reports
Midwestern University (US), Phoenix Children's Hospital (US), Mayo Clinic in Arizona (US)
National Institutes of Health, National Institute of Allergy and Infectious Diseases
Good health and well-being
Eosinophilic Esophagitis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon